[{"AccountsPayableCurrent_0_Q2_USD":9881000.0,"OperatingIncomeLoss_2_Q2_USD":16258000.0,"OperatingLeaseCost_1_Q2_USD":912000.0,"OperatingLeaseCost_2_Q2_USD":1614000.0,"OperatingLeaseLiability_0_Q2_USD":18907000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":2918000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":15989000.0,"OperatingLeasePayments_2_Q2_USD":1696000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":17669000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.044,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":18456000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q2_USD":23000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2_Q2_USD":-859000.0,"OtherLiabilitiesCurrent_0_Q2_USD":3964000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":24171000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":-1645000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":-2064000.0,"OtherOperatingActivitiesCashFlowStatement_2_Q2_USD":-255000.0,"OperatingIncomeLoss_1_Q2_USD":-5740000.0,"NumberOfReportableSegments_2_Q2_segment":2.0,"NonoperatingIncomeExpense_2_Q2_USD":-869000.0,"NonoperatingIncomeExpense_1_Q2_USD":-3326000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":646636000.0,"LiabilitiesCurrent_0_Q2_USD":158186000.0,"LineOfCredit_0_Q2_USD":0.0,"LineOfCreditFacilityMaximumBorrowingCapacity_0_Q2_USD":50000000.0,"LongTermDebtCurrent_0_Q2_USD":15000000.0,"LongTermDebtNoncurrent_0_Q2_USD":166084000.0,"LongTermInvestments_0_Q2_USD":19483000.0,"MinorityInterest_0_Q2_USD":77807000.0,"PaymentsForProceedsFromOtherInvestingActivities_2_Q2_USD":864000.0,"MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_1_Q2_USD":74000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":101409000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-49296000.0,"NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_2_Q2_USD":-49296000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-713000.0,"NetIncomeLoss_1_Q2_USD":-4126000.0,"NetIncomeLoss_2_Q2_USD":20810000.0,"NetIncomeLossAttributableToNoncontrollingInterest_1_Q2_USD":-6654000.0,"NetIncomeLossAttributableToNoncontrollingInterest_2_Q2_USD":-7062000.0,"MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_2_Q2_USD":191000.0,"PaymentsForRestructuring_2_Q2_USD":247000.0,"PaymentsToAcquireBusinessesNetOfCashAcquired_2_Q2_USD":45790000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":2642000.0,"ShareBasedCompensation_2_Q2_USD":7797000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q2_shares":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1_Q2_shares":4000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_2_Q2_shares":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q2_USD":16095000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":4625000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":13.03,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_2_Q2_shares":0.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":103736000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1_Q2_USD":14.9,"ShortTermLeaseCost_2_Q2_USD":329000.0,"StockholdersEquity_0_Q2_USD":141557000.0,"StockholdersEquityChangeInReportingEntity_2_Q2_USD":-55924000.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q2_USD":219364000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q2_USD":314000.0,"TaxesPayableCurrent_0_Q2_USD":2385000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":41805347.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":41802840.0,"ShortTermLeaseCost_1_Q2_USD":212000.0,"Liabilities_0_Q2_USD":427272000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":69050000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":109816000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.001,"PreferredStockSharesAuthorized_0_Q2_shares":10000000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":15943000.0,"ProceedsFromIssuanceInitialPublicOffering_2_Q2_USD":107777000.0,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":330000.0,"ProceedsFromLongTermLinesOfCredit_2_Q2_USD":0.0,"ProceedsFromPaymentsForOtherFinancingActivities_2_Q2_USD":-11000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":191594000.0,"ProfitLoss_1_Q2_USD":-10780000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":8960000.0,"ProvisionForDoubtfulAccounts_1_Q2_USD":-550000.0,"ProvisionForDoubtfulAccounts_2_Q2_USD":-359000.0,"RepaymentsOfLongTermDebt_2_Q2_USD":7500000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":4836000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":5783000.0,"RestrictedCashCurrent_0_Q2_USD":2003000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-5167000.0,"ProfitLoss_2_Q2_USD":13748000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":41805347.0,"LeaseCost_2_Q2_USD":1943000.0,"InventoryValuationReserves_0_Q2_USD":1720000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_2_Q2_USD":641000.0,"BusinessCombinationContingentConsiderationLiabilityCurrent_0_Q2_USD":13220000.0,"BusinessCombinationContingentConsiderationLiabilityNoncurrent_0_Q2_USD":30421000.0,"BusinessCombinationIntegrationRelatedCosts_1_Q2_USD":3939000.0,"BusinessCombinationIntegrationRelatedCosts_2_Q2_USD":7135000.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":695000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":136065000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":138068000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":51229000.0,"CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations_2_Q2_USD":0.0,"CommitmentsAndContingencies_0_Q2_USD":null,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-4109000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":19771000.0,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_1_Q2_USD":-6648000.0,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_2_Q2_USD":-6882000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1_Q2_USD":-10757000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_2_Q2_USD":12889000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_1_Q2_USD":641000.0,"BusinessAcquisitionProFormaEarningsPerShareDiluted_1_Q2_USD":-0.03,"BusinessAcquisitionProFormaEarningsPerShareBasic_1_Q2_USD":-0.03,"AssetsCurrent_0_Q2_USD":290060000.0,"AccountsReceivableGrossCurrent_0_Q2_USD":105048000.0,"AccountsReceivableNetCurrent_0_Q2_USD":102029000.0,"AccruedBonusesCurrent_0_Q2_USD":12493000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":105246000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":468000.0,"AdditionalPaidInCapital_0_Q2_USD":146199000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":5853000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2_Q2_USD":7836000.0,"CostOfGoodsAndServicesSold_1_Q2_USD":33503000.0,"AllowanceForDoubtfulAccountsReceivable_0_Q2_USD":3019000.0,"AllowanceForDoubtfulAccountsReceivableRecoveries_1_Q2_USD":36000.0,"AllowanceForDoubtfulAccountsReceivableRecoveries_2_Q2_USD":72000.0,"AllowanceForDoubtfulAccountsReceivableWriteOffs_1_Q2_USD":278000.0,"AllowanceForDoubtfulAccountsReceivableWriteOffs_2_Q2_USD":684000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":21663037.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":21365213.0,"AssetImpairmentCharges_2_Q2_USD":5674000.0,"Assets_0_Q2_USD":646636000.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q2_USD":3019000.0,"CostOfGoodsAndServicesSold_2_Q2_USD":55725000.0,"CostOfGoodsAndServicesSoldDepreciationAndAmortization_1_Q2_USD":5618000.0,"CostOfGoodsAndServicesSoldDepreciationAndAmortization_2_Q2_USD":10854000.0,"Goodwill_0_Q2_USD":52135000.0,"GrossProfit_1_Q2_USD":76313000.0,"GrossProfit_2_Q2_USD":135869000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-9066000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":15389000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":1714000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":1641000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_Q2_USD":2917000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q2_USD":15797000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":9370000.0,"IncreaseDecreaseInOtherCurrentAssetsAndLiabilitiesNet_2_Q2_USD":13011000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q2_USD":257848000.0,"InterestIncomeExpenseNonoperatingNet_1_Q2_USD":-1681000.0,"InterestIncomeExpenseNonoperatingNet_2_Q2_USD":1195000.0,"InventoryFinishedGoods_0_Q2_USD":31538000.0,"InventoryGross_0_Q2_USD":35740000.0,"InventoryNet_0_Q2_USD":34020000.0,"InventoryRawMaterialsAndSupplies_0_Q2_USD":4202000.0,"IncreaseDecreaseInInventories_2_Q2_USD":-3913000.0,"LeaseCost_1_Q2_USD":1124000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_Q2_USD":-171000.0,"EffectiveIncomeTaxRateContinuingOperations_1_Q2_pure":0.189,"DebtInstrumentCarryingAmount_0_Q2_USD":182500000.0,"DebtInstrumentInterestRateStatedPercentage_0_Q2_pure":0.026,"DebtInstrumentUnamortizedDiscount_0_Q2_USD":457000.0,"DeferredCompensationSharebasedArrangementsLiabilityClassifiedNoncurrent_0_Q2_USD":0.0,"DeferredCompensationShareBasedArrangementsLiabilityCurrent_0_Q2_USD":10875000.0,"DeferredFinanceCostsNet_0_Q2_USD":959000.0,"DeferredIncomeTaxAssetsNet_0_Q2_USD":481000.0,"DeferredIncomeTaxLiabilitiesNet_0_Q2_USD":48410000.0,"EffectiveIncomeTaxRateContinuingOperations_2_Q2_pure":0.107,"DeferredTaxAssetsTaxCreditCarryforwards_0_Q2_USD":481000.0,"DepreciationAndAmortization_1_Q2_USD":1852000.0,"DepreciationAndAmortization_2_Q2_USD":3777000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":14663000.0,"DerivativeGainLossOnDerivativeNet_2_Q2_USD":1310000.0,"EarningsPerShareBasic_1_Q2_USD":-0.1,"EarningsPerShareBasic_2_Q2_USD":-0.12,"EarningsPerShareDiluted_1_Q2_USD":-0.1,"EarningsPerShareDiluted_2_Q2_USD":-0.12,"DeferredTaxLiabilitiesInvestments_0_Q2_USD":48410000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":41802840.0,"Ticker":"BVS","CIK":"1665988","name":"BIOVENTUS INC.","OfficialName":"Bioventus Inc. Class A Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"774491745.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Electromedical & Electrotherapeutic Apparatus","Market":"NASDAQ","SP500":"nan","filed":"20210811"}]